Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Acquisitions & Divestments (2020 - 2023)

Historic Change in Acquisitions & Divestments for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $52.3 million.

  • Terns Pharmaceuticals' Change in Acquisitions & Divestments rose 5610.62% to $52.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $237.8 million, marking a year-over-year increase of 10201.98%. This contributed to the annual value of $157.6 million for FY2024, which is 3374.96% down from last year.
  • According to the latest figures from Q4 2023, Terns Pharmaceuticals' Change in Acquisitions & Divestments is $52.3 million, which was up 5610.62% from $41.8 million recorded in Q3 2023.
  • Terns Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $92.0 million for Q2 2023, and its period low was $8.0 million during Q1 2020.
  • Over the past 4 years, Terns Pharmaceuticals' median Change in Acquisitions & Divestments value was $30.8 million (recorded in 2022), while the average stood at $34.2 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Change in Acquisitions & Divestments surged by 1067.65% in 2022, and later soared by 31682.83% in 2023.
  • Over the past 4 years, Terns Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $8.0 million in 2020, then skyrocketed by 68.92% to $13.5 million in 2021, then soared by 148.14% to $33.5 million in 2022, then surged by 56.11% to $52.3 million in 2023.
  • Its Change in Acquisitions & Divestments stands at $52.3 million for Q4 2023, versus $41.8 million for Q3 2023 and $92.0 million for Q2 2023.